Loading company…
Nucleonics develops RNA-interference-based therapies for viral and other diseases.
Founded in 2001, Nucleonics is a US biotechnology company developing RNA-interference-based therapies for viral and other diseases.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in